×
About 178,210 results

Overactive Bladder Linked to Multiple Unmet Socioeconomic Needs
https://www.medpagetoday.com/urology/urology/102005

Dec 1st, 2022 - Unmet socioeconomic needs had a significant association with overactive bladder (OAB), adding to evidence of a complex interaction between social determinants of health and OAB, researchers said. Stressors such as housing and food insecurity and concerns about personal health as much as tripled the odds of reported OAB symptoms. The stressors remained significant predictors for OAB after adjust...

FDA Greenlights First Fecal Microbiota Product
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/101991

Dec 1st, 2022 - The FDA has approved the first-ever fecal microbiota product, the agency announced on Wednesday. Rebyota was approved to prevent the recurrence of Clostridioides difficile (C. difficile) infection in adults who have already completed a course of antibiotics for recurrent C. difficile; it is not indicated for the first occurrence of C. difficile. The fecal microbiota product is prepared from sto...

Top 10 Unproven Infertility Tests and Treatments
https://www.medscape.com/viewarticle/984553

Dec 1st, 2022 - In 2019, a New York Times opinion piece titled, “The Big IVF Add-On Racket – This is no way to treat patients desperate for a baby”[1] alleged exploitation of infertility patients based on a Fertility and Sterility article, “Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.”[2] The desperation of infertility patients combined with their fin...

Fewer Neonatal Risks With Buprenorphine for Opioid Use Disorder in Pregnancy
https://www.medpagetoday.com/obgyn/pregnancy/101994

Dec 1st, 2022 - Buprenorphine treatment for pregnant patients with opioid use disorder (OUD) was linked with fewer neonatal risks compared with methadone therapy, but had similar maternal outcomes, an analysis of Medicaid data found. Neonatal abstinence syndrome (NAS) occurred in 52% of infants whose mothers took buprenorphine in the 30 days before delivery compared with 69% of those whose mothers took methado...

Mason Vitamins Inc. Voluntary Recalls Healthy Sense Daily Multiple with Iron Tablets and People's Choice Women's Daily Vitamins with Iron Tablets Sold in the U.S Due to Inconsistent Product Labeling
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732822

Mason Vitamins Inc. has issued a nationwide voluntary recall of the specific lot of Healthy Sense Daily Multiple with Iron and People's Choice Women's Daily Vitamins with Iron due to Vitamin A, Vitamin B12, Vitamin C, Vitamin E and Pantothenic Acid amounts being lower than the declared amount on the

Boston Baking Issues Allergy Alert on Undeclared Pecans in "Boston Baking Mini Cinnamon Crumb Cakes"
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732709

BOSTON BAKING, Inc. of Boston, MA, is recalling its 3-ounce, individually wrapped packages "Boston Baking Mini Cinnamon Crumb Cakes" food snacks sold exclusively at Whole Foods Market stores because they may contain undeclared pecans. People who have allergies to pecans run the risk of serious or li

Seed Ranch Flavor Co Issues Allergy Alert on Undeclared Soy in "Umami Everyday Sauce" and "Everything But The Sushi & Dumplings" Sauce
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732417

Seed Ranch Flavor Co. of Boulder, CO, is voluntarily recalling its 5 fl ounce bottles of "Umami Everyday Sauce" and "Everything But The Sushi & Dumplings" sauce because they contain undeclared soy. People who have allergies to soy run the risk of serious or life-threatening allergic reaction if they

Da Cheng Vegetarian Food Inc Issues Allergy Alert on Undeclared Egg Protein in Vegan Drumsticks
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732365

Da Cheng Vegetarian Food Inc. of El Monte, CA, is recalling its 45 case of "Vegan Drumsticks" because they may contain undeclared egg protein. People who have allergies to egg protein run the risk of serious or life-threatening allergic reaction if they consume these products.

Alzheimer's Drug Slows Decline, Trial Data Show
https://www.medpagetoday.com/neurology/alzheimersdisease/101972

Nov 30th, 2022 - Treatment with the investigational anti-amyloid agent lecanemab led to modestly less decline on cognitive and functional measures in the phase III CLARITY AD trial of early Alzheimer's disease, but was associated with adverse events. From a baseline score of about 3.2 on the Clinical Dementia Rating-Sum of Boxes (CDR-SB), mean worsening at 18 months was 1.21 with lecanemab and 1.66 with placebo...

Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focus
https://www.reuters.com/article/eisai-biogen-alzheimers/eisai-biogen-alzheimers-drug-slows-cognitive-decline-safety-for-some-becomes-focus-idUSL1N32O1QW

Nov 30th, 2022 - SAN FRANCISCO, Nov 29 (Reuters) - An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely-watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday. The drug, lecanemab, was associated with a type of brain swelling in 12.6% of trial patients, a side effect previously seen with simila...

Rocky Mountain Pies, LLC Issues Allergy Alert on Undeclared (Tree Nuts Almonds) in Red Button Vintage Creamery 31.88 oz French Silk Pie
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732918

Rocky Mountain Pies, LLC of Salt Lake City, Utah is recalling 31.88 oz French Silk Pie with inkjet code date 2 266, because it may contain undeclared almonds. People who have an allergy or severe sensitivity to Tree Nuts (almonds) run the risk of serious or life-threatening allergic reaction if they

Rocky Mountain Pies, LLC Issues Allergy Alert on Undeclared (Tree Nuts Almonds) in Red Button Vintage Creamery 31.88 oz French Silk Pie
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732917

Rocky Mountain Pies, LLC of Salt Lake City, Utah is recalling 31.88 oz French Silk Pie with inkjet code date 2 266, because it may contain undeclared almonds. People who have an allergy or severe sensitivity to Tree Nuts (almonds) run the risk of serious or life-threatening allergic reaction if they

Rituximab Raises Remission Rate in GPA Vasculitis
https://www.medscape.com/viewarticle/984760

Nov 30th, 2022 - More patients with granulomatosis with polyangiitis (GPA) were in remission at 6 months if they had received rituximab (Rituxan) rather than cyclophosphamide (Cytoxan) as induction therapy, according to a target trial emulation performed by the French Vasculitis Study Group (FVSG). Remission, which was defined as a score of zero on the validated Birmingham Vasculitis Activity Score (BVAS) and u...

Buprenorphine Linked With Lower Risk of Neonatal Harms Than Methadone
https://www.medscape.com/viewarticle/984779

Nov 30th, 2022 - Using buprenorphine for opioid use disorder in pregnancy was linked with a lower risk of neonatal side effects than using methadone, but the risk of adverse maternal outcomes was similar between the two treatments, according to new research. Elizabeth A. Suarez, PhD, MPH, with Brigham and Women's Hospital in Boston, led the study published online in the New England Journal of Medicine. Opioid u...

The TikTok Trend That Triggered a Diabetes Drug Shortage
https://www.medscape.com/viewarticle/984758

Nov 30th, 2022 - Weight loss advice is everywhere you look on social media, but one trend sweeping TikTok has led to shortages of an important diabetes drug.  Ozempic, a weekly injection that helps boost insulin sensitivity in people with type 2 diabetes, also suppresses appetite, which leads to weight loss. Stories of celebrities using the drug off-label to lose a few pounds have led to an explosion of interes...

One Dose of Acoziborole Led to Cure of 'Sleeping Sickness' Across Disease Stages
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/101970

Nov 29th, 2022 - A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as "sleeping sickness," suggesting its promise in interrupting transmission, a single-arm phase II/III trial showed. Over 18 months of follow-up, the treatment success rate was 95.2% in those with late-stage disease and 98.1% in the evalua...

The Surprising Failure of Vitamin D in Deficient Kids
https://www.medscape.com/viewarticle/984626

Nov 29th, 2022 - Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine. If you've watched this space over the years, you'll know that I'm not the biggest proponent of vitamin D supplementation. My basic gripe is that you've got all these observational studies linking lower levels of vitamin D to everything from dementia to falls to...

Stool Transplants May Boost Immunotherapy Success in Melanoma
https://www.medscape.com/viewarticle/984710

Nov 29th, 2022 - In advanced and metastatic melanoma patients, fecal microbiota transplant (FMT) from healthy donors in advance of anti–PD-1 immunotherapy led to a 75% clinical benefit rate, defined as complete response, partial response, or stable disease that lasted 6 months or longer. The results come from a small, single arm phase 1 study whose primary endpoint was safety. "We know that the gut microbiome h...

Pregnancy Not a Barrier to Interventional Cardiology Career
https://www.medscape.com/viewarticle/984724

Nov 29th, 2022 - A new collaborative position paper on radiation exposure during pregnancy states that pregnant women can safely work in an ionizing radiation environment if exposure to the fetus does not exceed certain dose thresholds. The position paper aims to "avoid discouraging" women from pursuing careers in interventional cardiology/electrophysiology (IC/EP) and to "dismantle" a barrier that says, "activ...

'Modest' Benefit for Lecanemab in Alzheimer's, Adverse Events Common
https://www.medscape.com/viewarticle/984737

Nov 29th, 2022 - UPDATED November 30, 2022 // Editor's note: This article has been updated with additional comments. SAN FRANCISCO — Widely anticipated data from a phase 3 trial of the monoclonal antibody lecanemab suggest the drug "modestly" relieved cognitive impairment in patients with early Alzheimer's disease (AD) — but at a cost. In the CLARITY AD trial, adverse events (AEs) were common compared with plac...